Found 169 matching trials
Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer N/A This is a feasibility study evaluating the use of a mathematical model to p...
Show More Location
University of New Mexico Comprehensive Cancer Center
Learn More & Join Trial
Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer PHASE2 Triple-negative breast cancer (TNBC) is a special type of breast cancer, en...
Show More Location
Guangdong general hospital
Learn More & Join Trial
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer PHASE2 This multi-center, open-label, phase II randomized controlled trial is to e...
Show More Location
Sun Yat-sen Memorial Hospital
Learn More & Join Trial
Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients PHASE2 A multicenter, prospective, open, randomized cohort, non controlled phase I...
Show More Learn More & Join Trial
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
Neoadjuvant Treatment of Breast Cancer N/A Observational investigation of participants who are given neoadjuvant treat...
Show More Location
National Institute of Oncolgy
Learn More & Join Trial
Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients PHASE4 This is a multicentric, open-label,non-randomized concurrent control, 1:1 m...
Show More Learn More & Join Trial
Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC PHASE2 Previous studies have shown that TNBC is sensitive to DNA crosslinking-rela...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer PHASE2 The purpose of this trial is to evaluate efficacy and toxicity of either th...
Show More Status
Active Not Recruiting
Location
Dept. of Oncology, Örebro University Hospital
Learn More & Join Trial
Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer PHASE2 This is an open-label, multicenter international trial in men and women wit...
Show More Status
Active Not Recruiting
Location
Sainte Catherine - Institut du Cancer Avignon Provence
Learn More & Join Trial